British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease

This document was published in 2025.

Abstract

Patients with inflammatory bowel disease (IBD) remain at increased risk for colorectal cancer and death from colorectal cancer compared with the general population despite improvements in inflammation control with advanced therapies, colonoscopic surveillance and reductions in environmental risk factors. This guideline update from 2010 for colorectal surveillance of patients over 16 years with colonic inflammatory bowel disease was developed by stakeholders representing UK physicians, endoscopists, surgeons, specialist nurses and patients with GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodological support. An a priori protocol was published describing the approach to three levels of statement: GRADE recommendations, good practice statements or expert opinion statements. A systematic review of 7599 publications, with appraisal and GRADE analysis of trials and network meta-analysis, where appropriate, was performed. Risk thresholding guided GRADE judgements.

We made 73 statements for the delivery of an IBD colorectal surveillance service, including outcome standards for service and endoscopist audit, and the importance of shared decision-making with patients. Core areas include: risk of colorectal cancer, IBDrelated post-colonoscopy colorectal cancer; service organisation and supporting patient concordance; starting and stopping surveillance, who should or should not receive surveillance; risk stratification, including web-based multivariate risk calculation of surveillance intervals; colonoscopic modalities, bowel preparation, biomarkers and artificial intelligence aided detection; chemoprevention; the role of non-conventional dysplasia, serrated lesions and non-targeted biopsies; management of dysplasia, both endoscopic and surgical, and the structure and role of the multidisciplinary team in IBD dysplasia management; training in IBD colonoscopic surveillance, sustainability (green endoscopy), costeffectiveness and patient experience. Sixteen research priorities are suggested

Read the guideline launch statement here.


Read More

BSG logo
Guidelines
Inflammatory Bowel Disease
British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease
clinical-resource/BSG-guidelines-on-colorectal-surveillance-in-IBD
This document was published in 2025.

BSG logo
Guidance
Care Bundles
Liver
Decompensated cirrhosis: an update of the BSG/BASL admission care bundle
clinical-resource/new-decompensated-cirrhosis-admission-care-bundle
This document was published in 2025.